Acadia Healthcare (NASDAQ:ACHC) Price Target Lowered to $70.00 at Mizuho

Acadia Healthcare (NASDAQ:ACHC) had its price target reduced by Mizuho from $84.00 to $70.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Mizuho’s target price indicates a potential upside of 5.87% from the company’s previous close.

ACHC has been the subject of several other reports. Bank of America reduced their price target on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a research note on Thursday. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. TD Cowen increased their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. UBS Group lifted their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Finally, Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a research report on Friday, January 5th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Moderate Buy” and an average price target of $88.89.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $66.12 on Friday. The firm’s fifty day moving average price is $76.77 and its two-hundred day moving average price is $77.52. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 0.67. The company has a market cap of $6.11 billion, a P/E ratio of -472.25, a P/E/G ratio of 1.97 and a beta of 1.31. Acadia Healthcare has a one year low of $64.74 and a one year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. During the same quarter in the prior year, the business earned $0.75 EPS. Acadia Healthcare’s quarterly revenue was up 9.1% on a year-over-year basis. Equities analysts expect that Acadia Healthcare will post 3.56 earnings per share for the current year.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. Vanguard Group Inc. grew its stake in shares of Acadia Healthcare by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after buying an additional 30,296 shares during the last quarter. Wellington Management Group LLP increased its holdings in Acadia Healthcare by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock worth $529,991,000 after purchasing an additional 152,783 shares in the last quarter. William Blair Investment Management LLC raised its position in Acadia Healthcare by 0.3% in the third quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock valued at $215,072,000 after purchasing an additional 10,062 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Acadia Healthcare by 1.1% during the third quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock valued at $88,482,000 after purchasing an additional 13,765 shares in the last quarter. Finally, Avidity Partners Management LP grew its holdings in shares of Acadia Healthcare by 61.8% during the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after purchasing an additional 441,692 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.